AcquisitionOther
ALPINE IMMUNE SCIENCES, INC. acquired Alpine Immune Sciences
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
ALPINE IMMUNE SCIENCES, INC. -> Alpine Immune Sciences · $65
Alpine is a compelling strategic fit for Vertex and furthers our ambition of using scientific innovation to create transformative medicines targeting serious diseases with high unmet need in specialty markets, said Reshma Kewalramani, M.D., FASN, Chief Execu
Open source record (SEC) ↗